Live Breaking News & Updates on Rare Glomerular Diseases

Stay updated with breaking news from Rare glomerular diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EU Nephrologists Foresee Travere/CSL Vifor's FILSPARITM

Data from Spherix Global Insights second annual EU IgAN patient chart audit indicates that even with the EMA approval of FILSPARITM (sparsentan),. ....

United Kingdom , Ionis Roche , European Medicines Agency , Spherix Network , Spherix Global Insight , Patient Chart , Iga Nephropathy , Rare Glomerular Diseases , Vera Therapeutics , Chart Dynamix , Global Insights , Spherix Global Insights , Ga Nephropathy , Lomerular Diseases , Csl Vifor , Sglt2 Inhibitors ,